Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways

Detalhes bibliográficos
Autor(a) principal: Cano, Amanda
Data de Publicação: 2021
Outros Autores: Fonseca, Elena, Ettcheto, Miren, Sánchez-López, Elena, de Rojas, Itziar, Alonso-Lana, Silvia, Morató, Xavier, Souto, Eliana B., Toledo, Manuel, Boada, Mercè, Marquié, Marta, Ruíz, Agustín
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/105326
https://doi.org/10.3390/ph14101057
Resumo: Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.
id RCAP_1bf8dcde7b41aa13fee873de7588576f
oai_identifier_str oai:estudogeral.uc.pt:10316/105326
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathwaysepilepsyneurodegenerative diseasesAlzheimer’s diseaseParkinson’s diseaseHuntington’s diseasemultiple sclerosisEpilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.MDPI2021-10-18info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/105326http://hdl.handle.net/10316/105326https://doi.org/10.3390/ph14101057eng1424-8247Cano, AmandaFonseca, ElenaEttcheto, MirenSánchez-López, Elenade Rojas, ItziarAlonso-Lana, SilviaMorató, XavierSouto, Eliana B.Toledo, ManuelBoada, MercèMarquié, MartaRuíz, Agustíninfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-02-17T09:36:59Zoai:estudogeral.uc.pt:10316/105326Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:21:55.237595Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
title Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
spellingShingle Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
Cano, Amanda
epilepsy
neurodegenerative diseases
Alzheimer’s disease
Parkinson’s disease
Huntington’s disease
multiple sclerosis
title_short Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
title_full Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
title_fullStr Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
title_full_unstemmed Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
title_sort Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
author Cano, Amanda
author_facet Cano, Amanda
Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
author_role author
author2 Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cano, Amanda
Fonseca, Elena
Ettcheto, Miren
Sánchez-López, Elena
de Rojas, Itziar
Alonso-Lana, Silvia
Morató, Xavier
Souto, Eliana B.
Toledo, Manuel
Boada, Mercè
Marquié, Marta
Ruíz, Agustín
dc.subject.por.fl_str_mv epilepsy
neurodegenerative diseases
Alzheimer’s disease
Parkinson’s disease
Huntington’s disease
multiple sclerosis
topic epilepsy
neurodegenerative diseases
Alzheimer’s disease
Parkinson’s disease
Huntington’s disease
multiple sclerosis
description Epilepsy is a chronic disease of the central nervous system characterized by an electrical imbalance in neurons. It is the second most prevalent neurological disease, with 50 million people affected around the world, and 30% of all epilepsies do not respond to available treatments. Currently, the main hypothesis about the molecular processes that trigger epileptic seizures and promote the neurotoxic effects that lead to cell death focuses on the exacerbation of the glutamate pathway and the massive influx of Ca2+ into neurons by different factors. However, other mechanisms have been proposed, and most of them have also been described in other neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, or multiple sclerosis. Interestingly, and mainly because of these common molecular links and the lack of effective treatments for these diseases, some antiseizure drugs have been investigated to evaluate their therapeutic potential in these pathologies. Therefore, in this review, we thoroughly investigate the common molecular pathways between epilepsy and the major neurodegenerative diseases, examine the incidence of epilepsy in these populations, and explore the use of current and innovative antiseizure drugs in the treatment of refractory epilepsy and other neurodegenerative diseases.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-18
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/105326
http://hdl.handle.net/10316/105326
https://doi.org/10.3390/ph14101057
url http://hdl.handle.net/10316/105326
https://doi.org/10.3390/ph14101057
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1424-8247
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134109519314944